Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Dairy Science|September 19, 2009
Monitoring the authenticity of low-fat yogurts by an artificial neural networkA G da Cruz, E H M Walter, R S Cadena, et al.Cancer Letters|April 9, 2008
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancerM Frattini, G Gallino, S Signoroni, et al.Cytopathology : Official Journal of the British Society for Clinical Cytology|December 10, 2014
Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experienceM Bongiovanni, F Molinari, M Eszlinger, et al.European Review for Medical and Pharmacological Sciences|April 10, 2020
Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapyS De Dosso, M Nucifora, N Sahnane, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Preoperative metronidazole treatment to evaluate its efficacy in reducing Fusobacterium nucleatum colonisation in colorectal cancer patients: a proof-of-concept trialS De Dosso, D Christoforidis, E Merlo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2008
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patientsF Perrone, A Lampis, M Orsenigo, et al.British Journal of Cancer|January 26, 2013
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patientsV Martin, L Landi, F Molinari, et al.British Journal of Cancer|November 26, 2009
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patientsI Zlobec, F Molinari, M Kovac, et al.Leukemia & Lymphoma|October 12, 2020
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter studyC Willekens, R Rahme, M Duchmann, et al.Pageof 2